Azenta Inc
NASDAQ:AZTA
Relative Value
The Relative Value of one AZTA stock under the Base Case scenario is 57.62 USD. Compared to the current market price of 55.35 USD, Azenta Inc is Undervalued by 4%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AZTA Competitors Multiples
Azenta Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Azenta Inc
NASDAQ:AZTA
|
3.1B USD | 4.8 | -164.5 | 108.4 | -30.9 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
222B USD | 5.2 | 37 | 22.9 | 33.5 | ||
US |
Danaher Corp
NYSE:DHR
|
183.3B USD | 4.2 | 22.7 | 16.5 | 20.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.3B CHF | 5.6 | 57 | 19.6 | 28.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.2B USD | 6.1 | 33.3 | 26.6 | 32 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.2B USD | 2.8 | 30.3 | 16.5 | 25.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 47.1 | 32.7 | 39.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.9 | 26.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.1 | 17.2 | 26.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19B EUR | 7 | 74.5 | 32.1 | 52.7 |